Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Larissa – page 19

225 clinical trials in Larissa, Greece across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Larissa at a glance
225
clinical trials
  • Research sites5
Type of trial
Recruitment status
Quick filters

225 trials in Larissa

Open in trial search

Breast cancer

Not recruiting

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:Pfizer Inc.

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Thalassaemia alpha

Not recruiting

Study on Luspatercept for Treating Anemia in Adults and Adolescents with Alpha-Thalassemia

Registered drug
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Luspatercept
  • Sponsor:Celgene Corp.

Bladder cancer

Not recruiting

Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Antipsychotics
  • Sponsor:Gilead Sciences Inc.

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Colestyramine
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Cenerimod
  • Sponsor:Viatris Innovation GmbH

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Gilead Sciences Inc.

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Larissa

What the registry says about research in the country

01 Oncology Research

Advanced clinical trials focusing on head and neck cancer, lung cancer, and prostate cancer treatments. Studies evaluate novel therapeutic combinations and targeted approaches for improved patient outcomes.

  • Non-small cell lung cancer therapies
  • Metastatic prostate cancer treatments
  • Head and neck squamous cell carcinoma

Research emphasizes combination therapies and innovative treatment approaches for various cancer types.

02 Autoimmune Conditions

Comprehensive studies investigating treatments for systemic lupus erythematosus, Sjögren's syndrome, and other autoimmune disorders. Trials focus on evaluating new therapeutic agents and their long-term safety profiles.

  • Lupus management strategies
  • Sjögren's syndrome treatments
  • Inflammatory disease therapies

Research aims to develop more effective treatments for chronic autoimmune conditions.

03 Cardiovascular Research

Studies examining heart failure prevention and cardiovascular disease management. Trials evaluate new medications and combination therapies to reduce cardiovascular events and improve patient outcomes.

  • Heart failure prevention strategies
  • Cardiovascular risk reduction
  • Lipoprotein management

Focus on preventive measures and innovative treatments for cardiovascular conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.